292 related articles for article (PubMed ID: 34861803)
41. Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
Wei H; Li L; Zhang H; Xu F; Chen L; Che G; Wang Y
Cell Cycle; 2021 Jan; 20(2):166-178. PubMed ID: 33413028
[TBL] [Abstract][Full Text] [Related]
42. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
Yang B; Zhang B; Qi Q; Wang C
BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
[TBL] [Abstract][Full Text] [Related]
43. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of circ_0000353 impedes the proliferation and metastasis of non-small cell lung cancer cells via adsorbing miR-411-5p and increasing forkhead box O1.
Zhao WX; Tang YL; Wang WH; Bao MW
Cancer Biomark; 2020; 29(1):25-37. PubMed ID: 32568175
[TBL] [Abstract][Full Text] [Related]
45. Circ_0025039 acts an oncogenic role in the progression of non-small cell lung cancer through miR-636-dependent regulation of CORO1C.
Wang L; Zeng C; Chen Z; Qi J; Huang S; Liang H; Huang S; Ou Z
Mol Cell Biochem; 2022 Mar; 477(3):743-757. PubMed ID: 35034254
[TBL] [Abstract][Full Text] [Related]
46. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
Wang L; Zhang Z; Tian H
J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
[TBL] [Abstract][Full Text] [Related]
47. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
Sun G; Tian J; Xiao Y; Zeng Y
Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
[TBL] [Abstract][Full Text] [Related]
48. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
49. 2-methoxyestradiol restrains non-small cell lung cancer tumorigenesis through regulating circ_0010235/miR-34a-5p/NFAT5 axis.
Zhang Y; Mi Y; He C
Thorac Cancer; 2023 Aug; 14(22):2105-2115. PubMed ID: 37439026
[TBL] [Abstract][Full Text] [Related]
50. circBIRC6 contributes to the development of non-small cell lung cancer via regulating microRNA-217/amyloid beta precursor protein binding protein 2 axis.
Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
Chin Med J (Engl); 2022 Mar; 135(6):714-723. PubMed ID: 35191420
[TBL] [Abstract][Full Text] [Related]
51. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis.
Hao D; Li Y; Shi J; Jiang J
Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322
[TBL] [Abstract][Full Text] [Related]
52. Circular RNA ABCB10 promotes non-small cell lung cancer progression by increasing E2F5 expression through sponging miR-584-5p.
Ma D; Qin Y; Huang C; Chen Y; Han Z; Zhou X; Liu H
Cell Cycle; 2020 Jul; 19(13):1611-1620. PubMed ID: 32420810
[TBL] [Abstract][Full Text] [Related]
53. Circ_0020123 promotes non-small cell lung cancer progression via miR-146a-5p mediated regulation of EIF4G2 expression.
Wei Z; Liu J; Hui G; Luan X
Thorac Cancer; 2024 Jan; 15(1):44-56. PubMed ID: 37993106
[TBL] [Abstract][Full Text] [Related]
54. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
[TBL] [Abstract][Full Text] [Related]
55. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs.
Zhang Y; Zeng S; Wang T
Bioengineered; 2021 Dec; 12(2):12767-12777. PubMed ID: 34747300
[TBL] [Abstract][Full Text] [Related]
56. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
[TBL] [Abstract][Full Text] [Related]
57. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
[TBL] [Abstract][Full Text] [Related]
58. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
59. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.
Wu Y; Xie J; Wang H; Hou S; Feng J
J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749
[TBL] [Abstract][Full Text] [Related]
60. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
Pang J; Ye L; Zhao D; Zhao D; Chen Q
Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
